BCL2L11

BCL2L11 Full Name

BCL2-like 11 (apoptosis facilitator)

BCL2L11 Introduction

BCL2L11 (BCL-2-like protein 11), commonly known as BIM (Bcl-2 interacting mediator of cell death), is a pro-apoptotic protein belonging to the BH3-only subgroup of the BCL-2 family. The gene encoding BCL2L11 is located on human chromosome 2q13 and produces a protein of approximately 198 amino acids with a molecular weight of about 22 kDa. BCL2L11 is widely expressed in various human tissues, including the immune system, hematopoietic cells, and many epithelial tissues. As a BH3-only protein, BIM contains a single BCL-2 homology 3 (BH3) domain that mediates its interactions with anti-apoptotic BCL-2 family members such as BCL-2, BCL-XL, BCL-W, MCL-1, and A1/BFL-1. BIM is a critical initiator of apoptosis in response to multiple stimuli, including growth factor withdrawal, cytokine deprivation, endoplasmic reticulum stress, and certain chemotherapeutic agents. Through its interactions with anti-apoptotic proteins, BIM activates the mitochondrial (intrinsic) apoptotic pathway, leading to cell death. BIM is essential for normal development and immune system homeostasis, and its dysregulation has been implicated in cancer, autoimmunity, and degenerative diseases.

Figure 1. Strcuture of BCL2L11.

Mechanisms of Action: Activating the Intrinsic Apoptotic Pathway
BIM functions as a key initiator of the intrinsic (mitochondrial) apoptotic pathway. Under normal conditions, BIM is sequestered from its targets through interactions with the dynein light chain (DLC1/2) and the dynein motor complex, localizing it to the microtubule-associated dynein complex. Upon apoptotic stimulation (such as growth factor withdrawal or cytokine deprivation), BIM is released from the dynein complex and translocates to the mitochondria. Once at the mitochondria, BIM binds to and neutralizes anti-apoptotic BCL-2 family proteins (BCL-2, BCL-XL, MCL-1, etc.), thereby freeing the pro-apoptotic effectors BAX and BAK.

Regulation of BIM Expression and Activity
BIM is tightly regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational mechanisms. Transcriptional regulation: BIM expression is induced by the forkhead box O (FOXO) family of transcription factors (FOXO1, FOXO3a, FOXO4) in response to growth factor withdrawal or stress. The tumor suppressor p53 also induces BIM expression in response to DNA damage. Cytokines and growth factors (such as IL-3, IL-6, and EGF) suppress BIM transcription through the PI3K/AKT pathway, which phosphorylates and inactivates FOXO factors. Post-translational regulation: BIM is phosphorylated at multiple serine residues by various kinases, including ERK, JNK, and AKT.

Alternate Names for BCL2L11

BCL2L11; BCL2-like 11 (apoptosis facilitator); BAM; BIM; BOD; bcl-2-like protein 11; bcl-2 interacting protein Bim; bcl-2-related ovarian death agonist; bcl-2 interacting mediator of cell death;